Theriva Biologics, Inc. (TOVX) is a publicly traded company in the Unknown sector. Across all available filings, 1 corporate insiders have executed 7 transactions totaling $160.0K, demonstrating a bullish sentiment with $160.0K in net insider flow. The most recent transaction on Jun 7, 2023 involved a purchase of 14,000 shares valued at $9.7K.
No significant insider buying has been recorded for TOVX in the recent period.
No significant insider selling has been recorded for TOVX in the recent period.
Based on recent SEC filings, insider sentiment for TOVX is bullish with an Insider Alignment Score of 100/100 and a net flow of $160.0K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Theriva Biologics, Inc. (TOVX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 1 insiders are actively trading TOVX stock, having executed 7 transactions in the past 90 days. The most active insider is Steven A. Shallcross (Executive), who has made 7 transactions totaling $160.0K.
Get notified when executives and directors at TOVX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 7, 2023 | A. Shallcross Steven | Executive | Purchase | 14,000 | $0.69 | $9.7K | |
| Jun 6, 2023 | A. Shallcross Steven | Executive | Purchase | 26,000 | $0.63 | $16.4K | |
| Feb 10, 2023 | A. Shallcross Steven | Executive | Purchase | 25,000 | $1.04 | $26.0K | |
| Feb 2, 2023 | A. Shallcross Steven | Executive | Purchase | 25,000 | $0.94 | $23.5K | |
| Jan 25, 2023 | A. Shallcross Steven | Executive | Purchase | 25,000 | $0.87 | $21.8K | |
| Jan 20, 2023 | A. Shallcross Steven | Executive | Purchase | 25,000 | $0.75 | $18.8K | |
| Dec 29, 2022 | A. Shallcross Steven | Executive | Purchase | 100,000 | $0.44 | $44.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 7 | $160.0K | 100.0% |
Insiders at Theriva Biologics, Inc. are accumulating shares at an accelerated pace. With 1 insiders making 7 transactions totaling $160.0K in purchases versus $0 in sales, the net buying activity of $160.0K signals strong executive confidence. Steven A. Shallcross (Executive) leads the buying activity with $160.0K in transactions across all time.